Phio Pharmaceuticals Corp.
Reduced size self-delivering RNAI compounds
Last updated:
Abstract:
The present invention relates to methods for in vivo administration of sd-rxRNA molecules.
Status:
Grant
Type:
Utility
Filling date:
7 Feb 2019
Issue date:
14 Sep 2021